Ceftazidime Sodium



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 15.8%
Infection 13.3%
Pseudomonas Infection 9.2%
Sepsis 6.7%
Pyrexia 5.8%
Device Related Infection 5.0%
Febrile Neutropenia 5.0%
Abdominal Sepsis 4.2%
Bronchiectasis 4.2%
Acute Myeloid Leukaemia 3.3%
Infectious Peritonitis 3.3%
Prophylactic Chemotherapy 3.3%
Urinary Tract Infection 3.3%
Bacterial Pyelonephritis 2.5%
Bronchitis 2.5%
Cystic Fibrosis 2.5%
Infection Prophylaxis 2.5%
Pneumonia 2.5%
Prophylaxis 2.5%
Pulmonary Tuberculosis 2.5%
Pyrexia 10.5%
Anaphylactic Shock 7.9%
Hypersensitivity 7.9%
Status Epilepticus 7.9%
Swollen Tongue 7.9%
Abortion Induced 5.3%
Diarrhoea 5.3%
Drug Interaction 5.3%
Liver Disorder 5.3%
Overdose 5.3%
Pseudomembranous Colitis 5.3%
Toxic Epidermal Necrolysis 5.3%
Agranulocytosis 2.6%
Anaphylactic Reaction 2.6%
Antibiotic Level Above Therapeutic 2.6%
Clostridium Difficile Colitis 2.6%
Culture Positive 2.6%
Death 2.6%
Dermatitis Bullous 2.6%
Dermatitis Exfoliative 2.6%
Secondary
Product Used For Unknown Indication 21.5%
Drug Use For Unknown Indication 12.9%
Pseudomonas Infection 11.7%
Device Related Infection 7.4%
Infection Prophylaxis 5.5%
Sepsis 5.5%
Stem Cell Transplant 3.7%
Abdominal Sepsis 3.1%
Hypertension 3.1%
Lymphocytic Leukaemia 3.1%
Unevaluable Event 3.1%
Acinetobacter Infection 2.5%
Cystic Fibrosis 2.5%
Enterobacter Infection 2.5%
Pneumonia 2.5%
Staphylococcal Infection 2.5%
Anticoagulant Therapy 1.8%
Bone Marrow Transplant 1.8%
Osteomyelitis 1.8%
Prophylaxis 1.8%
Eosinophilia 10.7%
Interstitial Lung Disease 10.7%
Abortion Induced 7.1%
Acute Respiratory Distress Syndrome 7.1%
Neutropenia 7.1%
Renal Tubular Necrosis 7.1%
Anaemia 3.6%
Ascites 3.6%
Bradycardia 3.6%
Clostridium Colitis 3.6%
Drug Interaction 3.6%
Dyspnoea 3.6%
Eosinophilic Pneumonia 3.6%
Headache 3.6%
Hepatotoxicity 3.6%
Hypotonia 3.6%
Infection 3.6%
International Normalised Ratio Increased 3.6%
Obstructive Airways Disorder 3.6%
Oculomucocutaneous Syndrome 3.6%
Concomitant
Product Used For Unknown Indication 31.5%
Prophylaxis 7.8%
Sepsis 6.5%
Pneumonia 6.3%
Acute Lymphocytic Leukaemia 5.3%
Pyrexia 4.8%
Acute Myeloid Leukaemia 4.4%
Cancer Pain 3.8%
Constipation 3.8%
Rheumatoid Arthritis 3.6%
Drug Use For Unknown Indication 3.4%
Breast Cancer 2.9%
Infection 2.9%
Pharyngitis 2.5%
Insomnia 2.1%
Hypertension 1.9%
Antifungal Prophylaxis 1.7%
Upper Respiratory Tract Inflammation 1.7%
Urinary Tract Infection 1.7%
Aspergillosis 1.5%
Death 13.5%
Thrombocytopenia 11.5%
Pyrexia 7.7%
Sepsis 5.8%
Cardiac Failure 3.8%
Drug Rash With Eosinophilia And Systemic Symptoms 3.8%
Epilepsy 3.8%
Infection 3.8%
Kidney Transplant Rejection 3.8%
Leukopenia 3.8%
Lung Neoplasm Malignant 3.8%
Pancytopenia 3.8%
Peritonitis 3.8%
Platelet Count Decreased 3.8%
Pneumonia 3.8%
Renal Failure 3.8%
Respiratory Failure 3.8%
Septic Shock 3.8%
Urine Output Decreased 3.8%
Vomiting 3.8%